Synopsis : Despite weakness in benchmark indices, several stocks witnessed sharp gains driven by fundraising plans, major project wins, and sector-specific tailwinds. Zee Entertainment, Reliance Infrastructure, EMS, and pharma stocks emerged as key outperformers as investors sought opportunities amid broader market volatility.
Benchmark Indices Trade Lower Amid Global Concerns
Indian equity markets remained under pressure on June 8, with the Nifty 50 trading near the 23,200 mark and the Sensex hovering around 73,700 by midday. Investor sentiment turned cautious following a sharp decline in South Korea’s KOSPI index and renewed geopolitical tensions in the Middle East.
However, several stocks managed to outperform the broader market on the back of company-specific developments.
Reliance Infrastructure Hits Upper Circuit Again
Reliance Infrastructure continued its strong momentum, rising 5% and remaining locked at its upper circuit for the sixth consecutive trading session.
Key Highlights:
- Stock gained nearly 33% over the last six trading sessions.
- Rally fueled by the company's move to seek a review of insolvency-related surveillance norms.
- Investors are reassessing the company's near-term prospects after a prolonged period of weakness.
IT Stocks Defy Market Weakness
The IT sector showed resilience despite the broader selloff, with several technology stocks trading in positive territory.
Top IT Gainers:
- Tech Mahindra: +1.44%
- Mphasis: +1.02%
- Persistent Systems: +0.51%
- HCL Technologies: +0.29%
- Infosys: Marginal gains
Midcap IT Stocks in Focus:
- D-Link India: +3.38%
- Rashi Peripherals: +1.83%
- Tata Technologies: +1.06%
- C.E. Info Systems: +0.87%
Continued buying interest in technology stocks helped the sector outperform the benchmark indices.
Pharma Stocks Extend Winning Streak
The Nifty Pharma index gained nearly 1.4%, extending its rally for a fourth straight session as investors shifted towards defensive sectors.
Leading Pharma Gainers:
- JB Chemicals & Pharmaceuticals: +1.8%
- Alkem Laboratories: +1.7%
- Mankind Pharma: +1.7%
- Torrent Pharmaceuticals: +1.3%
- Dr. Reddy’s Laboratories and Gland Pharma also traded higher.
The sector benefited from increased demand for defensive stocks amid heightened market uncertainty.
Zee Entertainment Surges on Fundraising Proposal
Zee Entertainment shares climbed nearly 4% after the company announced a board meeting scheduled for June 10 to consider fundraising options.
Key Developments:
- Board to evaluate equity fundraising through permissible routes.
- Possible options include private placements and preferential allotments.
- Proposal remains subject to shareholder and regulatory approvals.
The fundraising announcement boosted investor sentiment despite the company reporting a weak March-quarter performance.
DEE Development Engineers Hits New High
DEE Development Engineers surged 5% and touched a fresh 52-week high after updating investors on its growing order book.
What Drove the Rally?
- Strong order inflows improved business visibility.
- Stock has rallied nearly 285% from its January 2026 low.
- Continued demand from industrial and infrastructure projects remains supportive.
EMS Soars After Major Infrastructure Win
EMS Ltd. emerged as one of the biggest gainers of the day, jumping nearly 15%.
Project Details:
- Secured L-1 status for a major sewerage infrastructure project in Uttar Pradesh.
- Project includes sewer network construction and household connections across four wards in Varanasi.
- Order significantly strengthens the company’s project pipeline.
Investors welcomed the development as a positive catalyst for future revenue growth.
Market Outlook
While benchmark indices remained under pressure due to global uncertainties and risk-off sentiment, stock-specific opportunities continued to drive market action. Fundraising announcements, infrastructure project wins, and defensive sector buying helped select counters outperform the broader market.
Disclaimer : This article is for informational and educational purposes only and should not be considered investment advice. Investors should conduct their own research or consult a SEBI-registered financial advisor before making investment decisions.
.jpg)
